Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 02, 2025 10:00 ET | Source: Precipio, Inc.

Precipio Terminates Its ATM

NEW HAVEN, Conn., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), has terminated its ATM (At-The-Market) instrument with investment bank...
August 13, 2025 17:00 ET | Source: Precipio, Inc.

Precipio Announces its Q2-2025 Financial Results

NEW HAVEN, Conn., Aug. 13, 2025 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), filed its 10-Q report today. The following are the highlights of the Company’s...
July 31, 2025 16:30 ET | Source: Precipio, Inc.

Precipio Announces Q2-2025 Shareholder Update Call

NEW HAVEN, Conn., July 31, 2025 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), will be hosting its Q2-2025 corporate update call on August 14th, 2025 at 5:00...
July 11, 2025 16:30 ET | Source: Precipio, Inc.

Precipio Enters Into Agreement With Warrant Holder To Exercise Majority Of Warrants As Cashless

NEW HAVEN, Conn., July 11, 2025 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) has entered into an agreement with its largest warrant holder, amending the...
June 16, 2025 12:00 ET | Source: Precipio, Inc.

Precipio is requesting Shareholders/Brokers vote today to avoid costly adjournment and rescheduling of Annual Shareholders Meeting

NEW HAVEN, Conn., June 16, 2025 (GLOBE NEWSWIRE) -- Management of specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) is requesting that shareholders instruct their brokers to vote...
May 14, 2025 17:00 ET | Source: Precipio, Inc.

Precipio Announces its Q1-2025 Financial Results

NEW HAVEN, Conn., May 14, 2025 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), filed its 10-Q report today. The following are the highlights of the Company’s...
May 01, 2025 17:00 ET | Source: Precipio, Inc.

Precipio Announces Q1-2025 Shareholder Update Call

NEW HAVEN, Conn., May 01, 2025 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), will be hosting its Q1-2025 corporate update call on May 15th, 2025 at 5:00 PM...
March 17, 2025 17:00 ET | Source: Precipio, Inc.

Precipio Announces Q4 and year-end 2024 Shareholder Update Call

NEW HAVEN, Conn., March 17, 2025 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), will be hosting its Q4 and year end 2024 corporate update call on March 31st,...
February 25, 2025 09:30 ET | Source: Precipio, Inc.

Precipio Achieves Key Q4-2024 Financial Goals: Positive Adjusted EBITDA and Positive Cash Flow (unaudited)

NEW HAVEN, Conn., Feb. 25, 2025 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), announces that it has achieved two important financial goals in the last...
January 16, 2025 17:00 ET | Source: Precipio, Inc.

Precipio grants senior management performance-based awards instead of traditional time-vested ESOPs

NEW HAVEN, Conn., Jan. 16, 2025 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), announced that options granted to senior management on January 14 would vest...